News

Biotech stock Mirum Pharmaceuticals has rocketed 236% since its IPO in 2019. Shares are near a buy point after earnings.
US President Donald Trump’s overall approval rating remains steady at 42%, according to a Reuters/Ipsos poll, but support for ...
According to the report, 56% of Americans disapprove of how Trump is handling the economy, compared to 42% who approve.
President Donald Trump's approval ratings continue to fluctuate. Most recent polls report that his approval ratings are slightly lower than his unfavorable ratings. Here's a look at Trump's latest ...
President Donald Trump’s approval rating has taken a downward turn, according to the latest Morning Consult poll.
In addition, MO's prospects are significantly aided by the excellent use of cash flow through the ongoing share repurchases, ...
Whenever the spotlight is on the cruelty and excesses of Trump's mass deportation campaign, Americans like his immigration ...
According to Newsweek's latest tracker, the president's approval now stands at 46 percent, with 51 percent disapproving.
The university conducted the poll of 1,265 registered voters between June 5 and June 9 with a margin of error of +/-2.8 percentage points.
Kamala Harris’s campaign thought it knew exactly how to beat Donald Trump. With just weeks left before Election Day, it ...
President Donald Trump's public approval rating held steady over the last month, but Americans are becoming less supportive ...
President Donald Trump is the most well-liked Republican, but not by much, according to a new poll. In fact, Trump is doing worse than three Republicans in a key metric: net favorability, the Harvard ...